Zhejiang Xianju Pharmaceutical News

Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20241028

Oct 28 09:36

Xianju Pharmaceutical: Announcement of Board Resolutions

Oct 26 00:00

Xianju Pharmaceutical: Announcement of Supervisory Committee Resolutions

Oct 26 00:00

Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240904

Sep 4 09:32

Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240828

Aug 28 09:10

Xianju Pharmaceutical: Semi-Annual Report Supervisory Board Resolutions Announcement

Aug 27 00:00

Xianju Pharmaceutical: Announcement on renewing the Company\'s 2024 Audit Institution

Aug 27 00:00

Xianju Pharmaceutical: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024

Aug 27 00:00

Xianju Pharmaceutical: Semi-Annual Report Board Resolution Announcement

Aug 27 00:00

Zhejiang Xianju Pharmaceutical: Investor Relations Management Information for Zhejiang Xianju Pharmaceutical as of July 19th, 2024

Jul 19 08:46

Zhejiang Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240530

May 30 09:04

Zhejiang Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240522

May 22 08:54

Zhejiang Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240515

May 15 09:42

Zhejiang Xianju Pharmaceutical: Announcement on holding an investor reception day event

May 14 00:00

Zhejiang Xianju Pharmaceutical: Announcement on the approval of prednisolone tablets by the US FDA

May 7 00:00

Zhejiang Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240428

Apr 28 19:25

Zhejiang Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Activity Record Form 20240425

Apr 25 23:00

Xianju Pharmaceutical: 20240425 (2024-019) Announcement on the Forecast of Daily Related Transactions in 2024

Apr 25 00:00

Xianju Pharmaceutical: 2023 Independent Director Debriefing Report (Liu Bin)

Apr 25 00:00

Xianju Pharmaceutical: Notice on holding the 2023 online performance briefing

Apr 25 00:00